| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/03/2023 | 1.98% | Piper Sandler | $200 → $180 | Maintains | Neutral |
| 10/02/2023 | 27.48% | UBS | → $225 | Initiates Coverage On | → Neutral |
| 09/19/2023 | 35.98% | Mizuho | $240 → $240 | Maintains | Buy |
| 08/30/2023 | 30.31% | Citigroup | $195 → $230 | Maintains | Buy |
| 08/04/2023 | 24.65% | BMO Capital | $180 → $220 | Maintains | Market Perform |
| 08/04/2023 | 4.82% | Morgan Stanley | $185 → $185 | Reiterates | Overweight → Overweight |
| 08/04/2023 | 13.31% | Truist Securities | $150 → $200 | Maintains | Hold |
| 08/04/2023 | 35.98% | Baird | $205 → $240 | Maintains | Outperform |
| 08/04/2023 | 30.31% | Wells Fargo | $200 → $230 | Maintains | Overweight |
| 08/04/2023 | 33.14% | Oppenheimer | $200 → $235 | Maintains | Outperform |
| 08/04/2023 | 35.98% | Mizuho | $205 → $240 | Maintains | Buy |
| 08/04/2023 | 10.48% | Barclays | $165 → $195 | Maintains | Equal-Weight |
| 07/25/2023 | -6.52% | Barclays | $130 → $165 | Maintains | Equal-Weight |
| 07/24/2023 | 16.15% | Baird | $175 → $205 | Maintains | Outperform |
| 07/18/2023 | 16.15% | Keybanc | $175 → $205 | Maintains | Overweight |
| 07/12/2023 | — | OTR Global | Downgrades | Positive → Mixed | |
| 06/29/2023 | -15.01% | Berenberg | → $150 | Initiates Coverage On | → Hold |
| 05/31/2023 | 13.31% | Wells Fargo | $180 → $200 | Maintains | Overweight |
| 05/08/2023 | -26.35% | Barclays | $155 → $130 | Maintains | Equal-Weight |
| 05/05/2023 | -12.18% | BMO Capital | $190 → $155 | Maintains | Market Perform |
| 05/05/2023 | 1.98% | Wells Fargo | $200 → $180 | Maintains | Overweight |
| 05/05/2023 | 21.81% | Mizuho | $235 → $215 | Maintains | Buy |
| 05/05/2023 | -6.52% | Goldman Sachs | $240 → $165 | Downgrades | Buy → Neutral |
| 04/20/2023 | 5.95% | Keybanc | $174 → $187 | Maintains | Overweight |
| 04/17/2023 | 13.31% | Oppenheimer | → $200 | Reiterates | → Outperform |
| 04/17/2023 | 33.14% | Mizuho | $255 → $235 | Maintains | Buy |
| 04/14/2023 | 7.65% | BMO Capital | $170 → $190 | Maintains | Market Perform |
| 02/03/2023 | -0.85% | Canaccord Genuity | $150 → $175 | Maintains | Buy |
| 02/03/2023 | 4.82% | Morgan Stanley | $190 → $185 | Maintains | Overweight |
| 02/03/2023 | -9.35% | Piper Sandler | $140 → $160 | Maintains | Neutral |
| 01/19/2023 | 1.98% | Jefferies | $150 → $180 | Maintains | Buy |
| 01/06/2023 | 13.31% | Wells Fargo | $250 → $200 | Maintains | Overweight |
| 01/05/2023 | -15.01% | Jefferies | → $150 | Upgrades | Hold → Buy |
| 12/22/2022 | 7.65% | Baird | $210 → $190 | Maintains | Outperform |
| 11/29/2022 | -14.45% | BMO Capital | $160 → $151 | Maintains | Market Perform |
| 11/11/2022 | 7.65% | Morgan Stanley | $375 → $190 | Maintains | Overweight |
| 11/07/2022 | 18.98% | Citigroup | $375 → $210 | Maintains | Buy |
| 11/04/2022 | 41.64% | Wells Fargo | $325 → $250 | Maintains | Overweight |
| 11/04/2022 | -9.35% | BMO Capital | $295 → $160 | Maintains | Market Perform |
| 11/04/2022 | -16.71% | Macquarie | $287 → $147 | Downgrades | Outperform → Neutral |
| 11/04/2022 | 50.14% | Goldman Sachs | $300 → $265 | Maintains | Buy |
| 11/04/2022 | 18.98% | Baird | $380 → $210 | Maintains | Outperform |
| 11/04/2022 | 44.48% | Mizuho | $320 → $255 | Maintains | Buy |
| 11/04/2022 | — | Piper Sandler | Downgrades | Overweight → Neutral | |
| 10/31/2022 | 24.65% | Jefferies | $260 → $220 | Maintains | Hold |
| 10/20/2022 | 112.46% | Morgan Stanley | $430 → $375 | Maintains | Overweight |
| 10/17/2022 | 81.3% | Mizuho | $360 → $320 | Maintains | Buy |
| 08/08/2022 | 64.31% | Wolfe Research | $240 → $290 | Maintains | Outperform |
| 08/05/2022 | 41.64% | Truist Securities | $220 → $250 | Maintains | Hold |
| 08/05/2022 | 60.34% | Piper Sandler | $249 → $283 | Maintains | Overweight |
| 08/05/2022 | 115.3% | Baird | $520 → $380 | Maintains | Outperform |
| 07/22/2022 | 112.46% | Citigroup | $435 → $375 | Maintains | Buy |
| 07/22/2022 | 57.51% | Keybanc | $338 → $278 | Maintains | Overweight |
| 07/20/2022 | 45.61% | Bernstein | → $257 | Initiates Coverage On | → Outperform |
| 07/13/2022 | 41.08% | Piper Sandler | $371 → $249 | Maintains | Overweight |
| 07/11/2022 | 143.63% | Morgan Stanley | $460 → $430 | Maintains | Overweight |
| 06/27/2022 | 69.97% | Goldman Sachs | $279 → $300 | Upgrades | Neutral → Buy |
| 05/23/2022 | 1.98% | Jefferies | $275 → $180 | Maintains | Hold |
| 05/18/2022 | 69.97% | Wells Fargo | $400 → $300 | Maintains | Overweight |
| 05/16/2022 | 103.97% | Mizuho | $500 → $360 | Maintains | Buy |
| 04/29/2022 | 160.62% | Morgan Stanley | $505 → $460 | Maintains | Overweight |
| 04/22/2022 | 126.63% | Wells Fargo | $425 → $400 | Maintains | Overweight |
| 04/08/2022 | 117.56% | Piper Sandler | $414 → $384 | Maintains | Overweight |
| 04/08/2022 | 124.93% | Keybanc | $442 → $397 | Maintains | Overweight |
| 03/24/2022 | 112.46% | Truist Securities | $400 → $375 | Maintains | Hold |
| 03/15/2022 | 140.79% | Wells Fargo | $500 → $425 | Maintains | Overweight |
| 01/28/2022 | 86.97% | Cowen & Co. | $325 → $330 | Maintains | Market Perform |
| 01/20/2022 | 84.14% | Cowen & Co. | $380 → $325 | Maintains | Market Perform |
| 12/16/2021 | 112.46% | Goldman Sachs | → $375 | Initiates Coverage On | → Neutral |
| 10/29/2021 | 197.45% | Mizuho | $440 → $525 | Maintains | Buy |
| 10/29/2021 | 183.29% | Wells Fargo | $475 → $500 | Maintains | Overweight |
| 10/29/2021 | 183.29% | Oppenheimer | $420 → $500 | Maintains | Outperform |
| 10/22/2021 | 186.12% | Morgan Stanley | $320 → $505 | Maintains | Overweight |
| 10/19/2021 | 103.97% | Cowen & Co. | $290 → $360 | Maintains | Market Perform |
| 10/08/2021 | 149.29% | Mizuho | $370 → $440 | Maintains | Buy |
| 08/31/2021 | 126.63% | Wolfe Research | → $400 | Initiates Coverage On | → Outperform |
| 08/30/2021 | 126.63% | Wolfe Research | → $400 | Initiates Coverage On | → Outperform |
| 07/30/2021 | 81.3% | Morgan Stanley | $292 → $320 | Maintains | Overweight |
| 07/30/2021 | 74.5% | Piper Sandler | $259 → $308 | Maintains | Overweight |
| 07/30/2021 | 52.97% | Truist Securities | $200 → $270 | Maintains | Hold |
| 07/30/2021 | 84.14% | Canaccord Genuity | $275 → $325 | Maintains | Buy |
| 07/30/2021 | 84.14% | Wells Fargo | $275 → $325 | Maintains | Overweight |
| 07/30/2021 | 109.63% | Mizuho | $310 → $370 | Maintains | Buy |
| 07/22/2021 | — | Cowen & Co. | Downgrades | Outperform → Market Perform | |
| 07/16/2021 | 75.64% | Mizuho | $285 → $310 | Maintains | Buy |
| 06/29/2021 | 64.31% | Baird | $270 → $290 | Maintains | Outperform |
| 05/18/2021 | 35.98% | Jefferies | $250 → $240 | Maintains | Hold |
| 04/30/2021 | 55.81% | Canaccord Genuity | $260 → $275 | Maintains | Buy |
| 04/30/2021 | 65.44% | Morgan Stanley | $275 → $292 | Maintains | Overweight |
| 04/14/2021 | 64.31% | DA Davidson | $275 → $290 | Maintains | Buy |
| 04/14/2021 | 52.97% | Wells Fargo | $265 → $270 | Maintains | Overweight |
| 01/29/2021 | 52.97% | Mizuho | $260 → $270 | Maintains | Buy |
| 01/29/2021 | 44.48% | Cowen & Co. | $250 → $255 | Maintains | Outperform |
| 01/29/2021 | 55.81% | Morgan Stanley | $270 → $275 | Maintains | Overweight |
| 01/29/2021 | 52.97% | Keybanc | $255 → $270 | Maintains | Overweight |
| 01/19/2021 | 44.48% | KeyBanc | $240 → $255 | Maintains | Overweight |
| 11/30/2020 | 35.98% | Keybanc | $230 → $240 | Maintains | Overweight |
| 10/30/2020 | 4.82% | Truist Securities | $162 → $185 | Downgrades | Buy → Hold |
| 10/30/2020 | 27.48% | Canaccord Genuity | $200 → $225 | Maintains | Buy |
| 10/20/2020 | 30.31% | Keybanc | $196 → $230 | Maintains | Overweight |
| 09/16/2020 | 20.11% | Piper Sandler | → $212 | Initiates Coverage On | → Overweight |
| 07/31/2020 | 18.98% | Morgan Stanley | $200 → $210 | Maintains | Overweight |
| 07/31/2020 | 11.05% | Keybanc | $201 → $196 | Maintains | Overweight |
| 07/14/2020 | 13.31% | Morgan Stanley | $173 → $200 | Maintains | Overweight |
| 07/01/2020 | 13.88% | Keybanc | $163 → $201 | Maintains | Overweight |
| 05/26/2020 | 13.31% | Mizuho | $175 → $200 | Maintains | Buy |
| 05/15/2020 | 42.78% | Citigroup | → $252 | Initiates Coverage On | → Buy |
| 05/01/2020 | -1.98% | Morgan Stanley | $165 → $173 | Maintains | Overweight |
| 05/01/2020 | -3.68% | Oppenheimer | $155 → $170 | Maintains | Outperform |
| 03/27/2020 | -15.01% | Goldman Sachs | $170 → $150 | Maintains | Buy |
| 03/25/2020 | -6.52% | Morgan Stanley | $175 → $165 | Maintains | Overweight |
| 01/28/2020 | 1.98% | Wells Fargo | → $180 | Initiates Coverage On | → Overweight |
| 01/24/2020 | -6.52% | Canaccord Genuity | $150 → $165 | Maintains | Buy |
| 01/24/2020 | -6.52% | BMO Capital | $155 → $165 | Maintains | Market Perform |
| 01/24/2020 | 1.98% | Mizuho | $152 → $180 | Maintains | Buy |
| 01/24/2020 | -9.35% | Cowen & Co. | $152 → $160 | Maintains | Outperform |
| 01/24/2020 | -6.52% | B of A Securities | $150 → $165 | Reiterates | → Buy |
| 01/24/2020 | -7.65% | Keybanc | $150 → $163 | Maintains | Overweight |
| 01/13/2020 | — | Morgan Stanley | Upgrades | Equal-Weight → Overweight | |
| 12/20/2019 | -25.21% | Cleveland Research | → $132 | Initiates Coverage On | → Buy |
| 10/28/2019 | — | B of A Securities | Upgrades | Neutral → Buy | |
| 10/03/2019 | -8.22% | SunTrust Robinson Humphrey | → $162 | Initiates Coverage On | → Buy |
| 07/26/2019 | -15.01% | Baird | $120 → $150 | Maintains | Outperform |
| 07/26/2019 | -15.01% | Canaccord Genuity | $125 → $150 | Maintains | Buy |
| 07/26/2019 | -15.01% | Keybanc | $142 → $150 | Maintains | Overweight |
| 06/13/2019 | -23.51% | Deutsche Bank | $114 → $135 | Maintains | Hold |
| 06/13/2019 | -19.55% | Keybanc | $121 → $142 | Maintains | Overweight |
| 05/29/2019 | — | BTIG | Downgrades | Buy → Neutral | |
| 05/23/2019 | -17.85% | Morgan Stanley | $99 → $145 | Upgrades | Underweight → Equal-Weight |
| 05/09/2019 | -29.18% | Goldman Sachs | $115 → $125 | Upgrades | Neutral → Buy |
| 04/11/2019 | -32.01% | Baird | $110 → $120 | Maintains | Outperform |
| 04/11/2019 | -29.18% | Mizuho | $120 → $125 | Maintains | Buy |
| 04/02/2019 | -31.44% | Keybanc | $110 → $121 | Maintains | Overweight |
| 03/14/2019 | -32.01% | Mizuho | → $120 | Initiates Coverage On | → Buy |
| 02/28/2019 | -35.41% | Deutsche Bank | → $114 | Initiates Coverage On | → Hold |
| 01/15/2019 | — | Morgan Stanley | Downgrades | Equal-Weight → Underweight | |
| 11/13/2018 | — | BTIG | Upgrades | Neutral → Buy |
What is the target price for Atlassian (TEAM)?
The latest price target for Atlassian (NASDAQ: TEAM) was reported by Piper Sandler on November 3, 2023. The analyst firm set a price target for $180.00 expecting TEAM to rise to within 12 months (a possible 1.98% upside). 44 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Atlassian (TEAM)?
The latest analyst rating for Atlassian (NASDAQ: TEAM) was provided by Piper Sandler, and Atlassian maintained their neutral rating.
When is the next analyst rating going to be posted or updated for Atlassian (TEAM)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Atlassian, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Atlassian was filed on November 3, 2023 so you should expect the next rating to be made available sometime around November 3, 2024.
Is the Analyst Rating Atlassian (TEAM) correct?
While ratings are subjective and will change, the latest Atlassian (TEAM) rating was a maintained with a price target of $200.00 to $180.00. The current price Atlassian (TEAM) is trading at is $176.50, which is out of the analyst's predicted range.